These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8427944)
21. Preliminary evaluation of the anticonvulsant activity of a valproic acid analog: N-(2-propylpentanoyl) urea. Tantisira B; Tantisira MH; Patarapanich C; Sooksawate T; Chunngam T Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):151-64. PubMed ID: 9344228 [TBL] [Abstract][Full Text] [Related]
22. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice. Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722 [TBL] [Abstract][Full Text] [Related]
23. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid. Shimshoni JA; Bialer M; Wlodarczyk B; Finnell RH; Yagen B J Med Chem; 2007 Dec; 50(25):6419-27. PubMed ID: 17994680 [TBL] [Abstract][Full Text] [Related]
24. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid. Lee SY; Huh W; Jung JA; Yoo HM; Ko JW; Kim JR Drug Des Devel Ther; 2015; 9():4559-63. PubMed ID: 26309401 [TBL] [Abstract][Full Text] [Related]
25. The effects of sodium valproate and its metabolites (5-OH-VPA and 4-OH-VPA) on electroconvulsions in rats. Sobaniec W; Sobaniec-Lotowska M Mater Med Pol; 1994; 26(1):29-32. PubMed ID: 7808038 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and pharmacodynamics of valproate analogues in rats. I. Spiro[4.6]undecane-2-carboxylic acid. Liu MJ; Scott KR; Pollack GM Epilepsia; 1990; 31(4):465-73. PubMed ID: 2114971 [TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid. Mawasi H; Shekh-Ahmad T; Finnell RH; Wlodarczyk BJ; Bialer M Epilepsy Behav; 2015 May; 46():72-8. PubMed ID: 25863940 [TBL] [Abstract][Full Text] [Related]
28. Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential. Shekh-Ahmad T; Hen N; Yagen B; McDonough JH; Finnell RH; Wlodarczyk BJ; Bialer M Epilepsia; 2014 Feb; 55(2):353-61. PubMed ID: 24313671 [TBL] [Abstract][Full Text] [Related]
29. Anticonvulsant and neurotoxic activities of twelve analogues of valproic acid. Elmazar MM; Hauck RS; Nau H J Pharm Sci; 1993 Dec; 82(12):1255-8. PubMed ID: 8308706 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine. Hadad S; Bialer M Pharm Res; 1995 Jun; 12(6):905-10. PubMed ID: 7667199 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and pharmacological evaluation of prodrugs of valproic acid. Bodor N; Moon SC; Bruno-Blanch L Pharmazie; 2000 Mar; 55(3):184-6. PubMed ID: 10756537 [TBL] [Abstract][Full Text] [Related]
32. Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid. Spiegelstein O; Yagen B; Levy RH; Finnell RH; Bennett GD; Roeder M; Schurig V; Bialer M Pharm Res; 1999 Oct; 16(10):1582-8. PubMed ID: 10554101 [TBL] [Abstract][Full Text] [Related]
33. Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Zolkowska D; Andres-Mach M; Prisinzano TE; Baumann MH; Luszczki JJ Psychopharmacology (Berl); 2015 Jul; 232(14):2463-79. PubMed ID: 25697861 [TBL] [Abstract][Full Text] [Related]
34. The oral absorption of phospholipid prodrugs: in vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration. Dahan A; Duvdevani R; Shapiro I; Elmann A; Finkelstein E; Hoffman A J Control Release; 2008 Feb; 126(1):1-9. PubMed ID: 18082281 [TBL] [Abstract][Full Text] [Related]
35. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid. Coupez R; Nicolas JM; Browne TR Epilepsia; 2003 Feb; 44(2):171-8. PubMed ID: 12558570 [TBL] [Abstract][Full Text] [Related]
36. Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamide. Sobol E; Yagen B; Lamb JG; White HS; Wlodarczyk BJ; Finnell RH; Bialer M Epilepsy Res; 2007 Jan; 73(1):75-84. PubMed ID: 16997532 [TBL] [Abstract][Full Text] [Related]
37. Circadian variation in anticonvulsant activity of valproic acid in mice. Khedhaier WBC; Dridi I; Aouam K; Ben-Attia M; Reinberg A; Boughattas NA Biomed Pharmacother; 2017 Nov; 95():25-30. PubMed ID: 28826093 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and anticonvulsant evaluation of dimethylethanolamine analogues of valproic acid and its tetramethylcyclopropyl analogue. Shekh-Ahmad T; Bialer M; Yavin E Epilepsy Res; 2012 Feb; 98(2-3):238-46. PubMed ID: 22057163 [TBL] [Abstract][Full Text] [Related]
39. 1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model. Luszczki JJ; Antkiewicz-Michaluk L; Czuczwar SJ Neuropharmacology; 2006 Feb; 50(2):133-42. PubMed ID: 16153667 [TBL] [Abstract][Full Text] [Related]